Search

John D. Ulm

Examiner (ID: 10769, Phone: (571)272-0880 , Office: P/1649 )

Most Active Art Unit
1649
Art Unit(s)
1649, 1812, 1646, 1805
Total Applications
2240
Issued Applications
1195
Pending Applications
205
Abandoned Applications
843

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11873617 [patent_doc_number] => 09745373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Anti-CGRP compositions and use thereof' [patent_app_type] => utility [patent_app_number] => 13/476465 [patent_app_country] => US [patent_app_date] => 2012-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 76 [patent_no_of_words] => 50669 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476465 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/476465
Anti-CGRP compositions and use thereof May 20, 2012 Issued
Array ( [id] => 9491044 [patent_doc_number] => 20140141451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'ASSAY TO DETERMINE LRRK2 ACTIVITY IN PARKINSON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/118547 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22905 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118547 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/118547
Assay to determine LRRK2 activity in parkinson's disease May 17, 2012 Issued
Array ( [id] => 10156023 [patent_doc_number] => 09187784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'EphA4 is a disease modifier in motor neuron disease' [patent_app_type] => utility [patent_app_number] => 14/117591 [patent_app_country] => US [patent_app_date] => 2012-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14754 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117591 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/117591
EphA4 is a disease modifier in motor neuron disease May 13, 2012 Issued
Array ( [id] => 8489040 [patent_doc_number] => 20120288447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'PEPTIDE WHICH PASSES THROUGH BLOOD-BRAIN BARRIER AND TARGETS APOPTOSIS OF NEURODEGENERATIVE BRAIN DISEASE SITE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/469729 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8119 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13469729 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/469729
Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof May 10, 2012 Issued
Array ( [id] => 9397010 [patent_doc_number] => 20140094415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'HIGH-AFFINITY, DIMERIC INHIBITORS OF PSD-95 AS EFFICIENT NEUROPROTECTANTS AGAINST ISCHEMIC BRAIN DAMAGE AND FOR TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 14/116862 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21751 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116862 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/116862
High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain May 10, 2012 Issued
Array ( [id] => 8370147 [patent_doc_number] => 20120219541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'Therapeutic Compositions Comprising Monoterpenes' [patent_app_type] => utility [patent_app_number] => 13/468970 [patent_app_country] => US [patent_app_date] => 2012-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12350 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468970 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/468970
Therapeutic Compositions Comprising Monoterpenes May 9, 2012 Abandoned
Array ( [id] => 8442395 [patent_doc_number] => 20120259012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Treatment for Amyotrophic Lateral Sclerosis' [patent_app_type] => utility [patent_app_number] => 13/465740 [patent_app_country] => US [patent_app_date] => 2012-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10873 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465740 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/465740
Treatment for Amyotrophic Lateral Sclerosis May 6, 2012 Abandoned
Array ( [id] => 9537159 [patent_doc_number] => 20140161807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1' [patent_app_type] => utility [patent_app_number] => 14/113626 [patent_app_country] => US [patent_app_date] => 2012-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23621 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113626 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/113626
Methods of promoting CNS neuronal repair by inhibiting LRP-1 Apr 25, 2012 Issued
Array ( [id] => 9561178 [patent_doc_number] => 20140178892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'SCREENING METHODS BASED ON VESICLE MOBILITY' [patent_app_type] => utility [patent_app_number] => 14/131941 [patent_app_country] => US [patent_app_date] => 2012-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5575 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131941 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/131941
SCREENING METHODS BASED ON VESICLE MOBILITY Apr 23, 2012 Abandoned
Array ( [id] => 9596683 [patent_doc_number] => 20140193364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'TAM RECEPTOR LIGANDS, METABOLITES AND PRECURSORS THEREOF IN THE DETECTION AND MODULATION OF INFLAMMATORY NEUROPATHOLOGICAL DISEASE' [patent_app_type] => utility [patent_app_number] => 14/110685 [patent_app_country] => US [patent_app_date] => 2012-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12228 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110685 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/110685
TAM RECEPTOR LIGANDS, METABOLITES AND PRECURSORS THEREOF IN THE DETECTION AND MODULATION OF INFLAMMATORY NEUROPATHOLOGICAL DISEASE Apr 3, 2012 Abandoned
Array ( [id] => 8441934 [patent_doc_number] => 20120258550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/438770 [patent_app_country] => US [patent_app_date] => 2012-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36918 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438770 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/438770
REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF Apr 2, 2012 Abandoned
Array ( [id] => 8951410 [patent_doc_number] => 20130197192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'Method and Composition for Crystallizing G Protein-Coupled Receptors' [patent_app_type] => utility [patent_app_number] => 13/436709 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14811 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13436709 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/436709
Method and composition for crystallizing G protein-coupled receptors Mar 29, 2012 Issued
Array ( [id] => 8301421 [patent_doc_number] => 20120183975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Taste Receptors Of The T1R Family From Domestic Dog' [patent_app_type] => utility [patent_app_number] => 13/432816 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25148 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432816 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/432816
Taste receptors of the T1R family from domestic dog Mar 27, 2012 Issued
Array ( [id] => 12364224 [patent_doc_number] => 09956268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Neuropeptide Y treatment of autoimmune disease [patent_app_type] => utility [patent_app_number] => 13/431154 [patent_app_country] => US [patent_app_date] => 2012-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7880 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13431154 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/431154
Neuropeptide Y treatment of autoimmune disease Mar 26, 2012 Issued
Array ( [id] => 9441076 [patent_doc_number] => 08710186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Taste receptors of the T1R family from domestic cat' [patent_app_type] => utility [patent_app_number] => 13/430273 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 28612 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430273 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/430273
Taste receptors of the T1R family from domestic cat Mar 25, 2012 Issued
Array ( [id] => 9971159 [patent_doc_number] => 09018169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Peptides for suppressing inflammation' [patent_app_type] => utility [patent_app_number] => 13/981238 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13428 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981238 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/981238
Peptides for suppressing inflammation Mar 15, 2012 Issued
Array ( [id] => 8638257 [patent_doc_number] => 20130030059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/417660 [patent_app_country] => US [patent_app_date] => 2012-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 41620 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417660 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/417660
T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds Mar 11, 2012 Issued
Array ( [id] => 8266080 [patent_doc_number] => 20120165506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/417411 [patent_app_country] => US [patent_app_date] => 2012-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 39887 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417411 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/417411
NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF Mar 11, 2012 Abandoned
Array ( [id] => 9262150 [patent_doc_number] => 20130344079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PHENYLKETONURIA (PKU)' [patent_app_type] => utility [patent_app_number] => 14/003803 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17798 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003803 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/003803
Compositions and methods for diagnosing and treating phenylketonuria (PKU) Mar 7, 2012 Issued
Array ( [id] => 8381448 [patent_doc_number] => 20120225070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 13/414698 [patent_app_country] => US [patent_app_date] => 2012-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 44541 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414698 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/414698
METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS Mar 6, 2012 Abandoned
Menu